Related by context. All words. (Click for frequent words.) 83 Antimicrobial Agents 73 #th Annual Interscience 72 Interscience Conference 70 #th Interscience Conference 70 AACR NCI EORTC 68 Digestive Disease Week DDW 68 Digestive Disease Week 68 Hematology ASH Annual Meeting 68 st Annual Meeting 68 Cancer iSBTc 67 Molecular Targets 67 Biological Therapy 67 Therapeutics TCT 67 Opportunistic Infections CROI 67 Therapeutics TCT scientific 66 ASH Annual Meeting 66 ICAAC 66 Annual Transcatheter Cardiovascular 66 Hematology Annual Meeting 65 nd Annual Meeting 65 AACR San Antonio 65 Scientific Sessions 65 ECCMID 65 ASCO Annual Meeting 65 EORTC NCI AACR Symposium 65 Clinical Oncology Annual Meeting 65 Retroviruses 65 Gene Therapy ASGT 64 Genitourinary Cancers Symposium 64 ICAAC IDSA 64 Annual Scientific Sessions 64 Clinical Oncology ASCO Annual 64 Cancers Symposium 64 Gastrointestinal Cancers Symposium 64 Endocrine Society ENDO 64 Molecular Medicine Tri 64 Transcatheter Cardiovascular Therapeutics TCT 63 ADA Scientific Sessions 63 CROI 63 Medical Oncology ESMO 63 annual Transcatheter Cardiovascular 63 Liver EASL 62 Haemostasis ISTH 62 Hematology Meeting 62 Symposium SABCS 62 th Interscience Conference 62 Nephrology Renal Week 62 Hematology ASH 62 Rheumatology ACR Annual 62 AACR Meeting 62 Oncology ASTRO 62 Arteriosclerosis Thrombosis 62 AABB Annual Meeting 62 Scientific Meeting 62 Scientific Session 62 League Against Rheumatism 62 Late Breaker 62 Immunology Annual Meeting 62 Vascular Biology ATVB 61 Annual Interscience Conference 61 #nd EORTC NCI 61 Society CTOS 61 Endocrine Society Annual Meeting 61 Alzheimer Disease ICAD 61 Liver Diseases AASLD 61 Infectious Diseases ECCMID 61 Pediatric Academic Societies 61 Malignant Lymphoma 61 AACR #st Annual Meeting 61 Connective Tissue Oncology 61 ENDO 61 Prostate Cancer Symposium 60 SAEM Annual Meeting 60 Opportunistic Infections 60 Targeted Anticancer Therapies 60 European CanCer Organisation ECCO 60 Canaccord Adams Hepatitis C 60 Heart Failure Society 60 AUA Annual Meeting 60 Therapeutics Roundtable 60 & Immunology AAAAI 60 Annual ICAAC 60 Radiation Oncology ASTRO 60 AACR symposium 60 ECTRIMS 60 AHA Scientific Sessions 60 Clinical Microbiology 59 Therapeutic Radiology 59 EORTC NCI 59 UEGW 59 Interventional Radiology SIR 59 NSTI Nanotech 59 Microbiology ASM 59 ISPOR 59 AAO HNSF Annual Meeting 59 Breast Cancer Symposium 59 EORTC NCI AACR 59 #nd Annual Meeting 59 America HFSA 59 HCV NS5B polymerase 59 Antiviral Research 59 Neck Surgery Foundation 59 Canaccord Genuity Growth 58 BIOCOM Investor Conference 58 #st Annual Meeting 58 BIO InvestorForum 58 Pediatric Academic Societies PAS 58 Nephrology ASN Renal 58 Neurology Annual Meeting 58 Rheumatology Annual 58 SABCS 58 ACR ARHP 58 ERA EDTA 58 Related Disorders ICAD 58 Abstract Number 58 CTRC AACR San Antonio 58 Clinical Oncology Gastrointestinal Cancers 58 Preclinical Study 58 Human Genetics ASHG 58 Pediatric Academic Society 58 Chemotherapy ICAAC Infectious Diseases 58 Cardiovascular Therapeutics 58 ASMS Conference 58 Oral Fingolimod 58 Cachexia 58 AASLD 58 ASCO GI 58 ASCO Breast Cancer 57 Cambridge Healthtech Institute 57 AASLD Meeting 57 Clinical Oncology ASCO 57 EULAR Annual 57 AACR Annual Meeting 57 GTCbio 57 Liver Diseases 57 AACR EORTC NCI 57 Gastrointestinal Cancer 57 Cardiovascular Anesthesiologists 57 Oral Presentation 57 Diabetes EASD 57 ACR ARHP Annual 57 Breast Cancer Symposium SABCS 57 entitled Synergistic 57 Vascular Annual Meeting 57 Endocrine Society #nd 57 Selective Cardiac Myosin 57 Mass Spectrometry ASMS 57 ASCO Genitourinary Cancers Symposium 57 Transcatheter Cardiovascular Therapeutics 57 International Myeloma Workshop 57 Long Awaited Reality 57 Two Upcoming Investor 57 International Microwave Symposium 56 Digestive Diseases Week 56 Gastroenterology ACG Annual 56 Vaccine Adjuvant 56 ASCO GU 56 Related Viruses 56 AACR Frontiers 56 Neurology AAN 56 Preclinical Data 56 GASTRO 56 Cardiovascular Disease Epidemiology 56 Deforolimus 56 Midyear Clinical Meeting 56 & OTO EXPO 56 DDW ® 56 EASL 56 Therapeutic Radiation 56 Endocrine Society #st 56 #rd Annual CTRC 56 Controlled Release 56 #th Annual Retrovirus 56 BioProcess International 56 ASGT 56 Mineral Research ASBMR 56 Retrovirus Conference 56 Dendritic Cells 56 Pharmaceutical Scientists AAPS 56 Canaccord Genuity Musculoskeletal 56 HCV polymerase inhibitors 56 International Papillomavirus 56 Talabostat 56 AACR #nd Annual Meeting 56 Elvitegravir 56 Combination REOLYSIN R 56 Hematology ASH Meeting 56 Cancer Therapeutic 56 Antibody Therapeutics 56 Metastatic Melanoma 56 Advanced Neuroendocrine Tumors 56 Oligonucleotide Therapeutics Society 56 Biodefense Vaccines 55 Gynecologic Cancer Society 55 HIV Pathogenesis 55 Cell Biology ASCB 55 ® DDW 55 Fifth Decennial International 55 pralatrexate injection folate analogue 55 SAWC WHS 55 Double Blind Placebo 55 American Thoracic Society 55 OTO EXPO 55 Blinatumomab 55 Medicine SIIM 55 delafloxacin 55 Annual BIO 55 Personalized Immunotherapy 55 Antiviral Activity 55 oral proteasome inhibitor 55 Brentuximab Vedotin SGN 55 non nucleoside inhibitor 55 Hsp# Inhibitor 55 AACR IASLC Joint 55 ASBMR 55 Stem Cell Research ISSCR 55 Gynecologic Investigation 55 Expo DEMO 55 Advanced Renal Cell 55 ASM Biodefense 55 Randomized Phase 55 Belimumab 55 AAAS Annual Meeting 55 Endovascular Therapy ISET 55 Windhover Therapeutic Area 55 Clinical Trial Results 55 ThinkEquity Growth 55 BioPharm America 55 Cancer Therapeutics 55 Proc Am Soc 55 Clinical Oncology ASCO Gastrointestinal 55 Neuro Oncology SNO 54 Cystic Fibrosis Conference NACFC 54 ThinkEquity Partners Growth 54 Therapeutic Targets 54 BiTE ® 54 AAN Annual Meeting 54 Innate Immunity 54 Omacetaxine 54 AAG geldanamycin analog 54 Clinical Chemistry AACC 54 Keystone Symposia 54 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 54 transthyretin TTR mediated amyloidosis 54 Experimental Biology EB 54 Phase 2a Trial 54 Drugs Affecting Lipid 54 Pooled Analysis 54 Association EHA 54 Inc. Nasdaq IMGN 54 sorafenib tablets 54 PNP inhibitor 54 Oncology ESTRO 54 lexidronam injection 54 Cellular Immunology 54 FOLOTYN ® 54 Hormone Refractory Prostate Cancer 54 Phase 2a Study 54 America RSNA 54 ARVO 54 Biologic Therapy 54 INSPIRE Trial Phase III 54 Refractive Surgery ASCRS 54 Global Healthcare Unplugged 54 Clinical Virology Symposium 54 ECCO ESMO 54 Poster Presentation 54 selective kinase inhibitor 54 Bucindolol 54 pan HDAC inhibitor 54 AACR Symposium 54 TXPO 54 ESTRO 54 LD Micro 53 SPIE Photonics West 53 Chicago Multidisciplinary Symposium 53 DIA Annual Meeting 53 th Annual Interscience 53 FOLFOX6 chemotherapy regimen 53 Cardiology ESC Congress 53 assessing T DM1 53 Hypertension ASH 53 J.P. Morgan Healthcare 53 Venereology EADV 53 AIIM Exposition 53 histone deacetylase HDAC inhibitor 53 registrational Phase 53 Liver Meeting 53 Urology EAU 53 CYT# potent vascular disrupting 53 Metabolic Disorders 53 HFSA Annual 53 Abstract Accepted 53 VEITHsymposium 53 Exposition ACE# 53 CIMZIA TM certolizumab pegol 53 Bazedoxifene 53 PROSTASCINT R 53 Healthcare Tailwinds 53 REITWeek 53 Minimally Invasive Gynecology 53 JPMorgan SMid Cap 53 Electro Optics CLEO 53 NASDAQ CYTK announced 53 MT#/MEDI-# 53 plus Copegus R 53 II Clinical Trial 53 Interventions SCAI 53 Bortezomib 53 AAPS Annual Meeting 53 Clinical Trials Update 53 radezolid 53 JAK2 Inhibitor 53 Cardiostim 53 Inflammatory Arthritis 53 SPL# Gel vaginal microbicide 53 ON #.Na 53 AACR 53 evaluating tivozanib 53 Autoimmune Diseases 53 Female Urology 53 GTCbio 3rd 53 Announces Poster Presentations 53 Novel Oral 53 Retina Specialists 53 R lenalidomide 53 LSE ASM 53 Respiratory Society 53 EUROGIN 53 FASEB J. 53 Nephrology Annual Meeting 53 Addex Pharmaceuticals SIX ADXN 53 Hygiene ASTMH 53 Canaccord Adams Musculoskeletal 53 Outcomes Research ISPOR 53 fosbretabulin 53 Panzem R 53 Immunology ACAAI 52 Anesthesiologists Annual Meeting 52 IEEE MTT S 52 proteasome inhibitor 52 Multiple Sclerosis ECTRIMS 52 & Renshaw Techvest 52 Phase #b/#a clinical 52 Presents Positive 52 Epilepsy Society 52 Hematology 52 EuroPCR 52 Anesthesiologists ASA Annual Meeting 52 PEGylated interferon beta 1a 52 MEK inhibitor 52 Presents Preclinical Data 52 histone deacetylase inhibitor 52 RNAi Therapeutic 52 oral rivaroxaban 52 Poster Discussion 52 Annual Meeting 52 ACC.# 52 MTT S 52 Experimental Biology 52 DU #b 52 NASDAQ SLXP today 52 Craig Hallum Institutional Investor 52 Neoplasia 52 mGluR5 negative 52 Cancer Cachexia 52 orally inhaled migraine 52 Immunology AAAAI 52 Lung Transplantation 52 Investigative Dermatology 52 depsipeptide 52 angiotensin receptor blocker ARB 52 San Antonio Breast Cancer 52 DG# compounds targeting 52 Vascular Biology 52 Nephrol 52 Targanta Therapeutics Corporation 52 Needham Growth Conference 52 Atrial Fibrillation Symposium 52 ABRF 52 Applied Spectroscopy 52 Lighthouse Seminars 52 USENIX Security 52 Hyatt Harborside 52 novel histone deacetylase 52 evaluating mipomersen 52 Canaccord Adams Healthy Living 52 Rheumatology EULAR 52 Ocular Diseases 52 Spine Arthroplasty Society 52 novel VDA molecule 52 mitogen activated ERK kinase 52 Annual Institutional Investor 52 Hedgehog Pathway Inhibitor 52 CLEO QELS 52 Renshaw 9th 52 NYSE Alternext ULU 52 See CLINICAL PHARMACOLOGY 52 ORAL Sync 52 NAREIT REITWeek 52 NAREIT Investor 52 Recurrent Chest Wall 52 AACR NCI EORTC Molecular 52 Needham Growth Stock 52 Poster Presentations 52 AHIMA Convention 52 vascular disrupting agent 52 M2M Evolution 52 Romidepsin 52 Aflibercept 52 System Pharmacists ASHP 52 Beneficial Effects 52 Professional Sleep Societies 52 Safety Tolerability 52 Fiber Optic Engineers 52 MT# MEDI 52 Autoimmunity 52 CHEST 52 Clinical Dermatology 52 Antimicrobials 52 Phase 2b Clinical Trial 52 Nuvelo Announces 52 BiTE R 52 PKC# 52 PRNewswire FirstCall Tercica 52 Phase Ib Clinical Trial 52 Histocompatibility 52 Molecular Cancer 52 Inc. Nasdaq AVRX 52 Biophysical Society 51 American Roentgen Ray 51 Interoperability Showcase 51 Thoraxcenter Erasmus University 51 Biophysical Society Annual Meeting 51 Maternal Fetal Medicine SMFM 51 Antimicrobial Chemotherapy 51 Thomas Weisel Partners Tech# 51 Antibody Engineering 51 Endoscopic Surgeons SAGES 51 SIX RO ROG 51 Answer INTERNET TELEPHONY 51 SOUTHWESTERN SHOWCASE Investor 51 E CENP E 51 Antiviral Therapy 51 abstr 51 Wound Healing Society 51 Announces Presentation 51 Immunotherapeutic 51 Lung Cancer IASLC 51 Active Biotech NASDAQ OMX 51 ongoing Phase 1b 51 Am J Pathol 51 Denufosol 51 ALN TTR 51 PROactive Study 51 Dasatinib 51 metastatic castration resistant 51 orally administered inhibitor 51 Investor Luncheon 51 Meets Primary Endpoint 51 Gaylord Palms Hotel 51 selective inhibition 51 generation oxazolidinone 51 essential thrombocythemia ET 51 Aflibercept VEGF Trap 51 Selective Cardiac Myosin Activator 51 Poster Session 51 Neuropathic Pain 51 Varespladib 51 oral JAK1 51 J Am Coll 51 qui se déroulera à 51 candesartan cilexetil 51 American Psychosomatic Society 51 Kinase Inhibitor 51 Nutracon 51 Experimental Biology FASEB 51 Vical Incorporated 51 Phase 1b trial 51 vinca alkaloid 51 Minimally Invasive Cardiothoracic Surgery 51 Presents Preclinical 51 interferon gamma 1b 51 J Clin Oncol 51 sulodexide 51 ExTRACT TIMI 51 NAREIT REITWorld 51 recurrent glioma 51 Peptide Symposium 51 Pharmacoeconomics 51 Sipuleucel T 51 ASTRO Annual Meeting 51 Postgraduate Course 51 GVAX ® 51 Annual AIFA 51 journal Antimicrobial Agents 51 Completes Patient Enrollment 51 Lysosomal Disease Network 51 Systemic Sclerosis 51 Diabet Med 51 CTAP# Capsules 51 J Am Soc 51 DoDIIS Worldwide Conference 51 BIO Windhover 51 Initiates Clinical Trial 51 Hypertension ESH 51 OTCBB AOLS announced 51 SCAI Annual 51 Research IADR 51 Clinical Oncologists 51 Immunologists 51 CLARITY TIMI 51 LymphoStat B TM 51 EULAR 51 Neurological Surgeons Annual Meeting 51 Boceprevir 51 By JAMAAL ABDUL 51 Molecular Origins 51 number NCT# ClinicalTrials.gov 51 Annual LD MICRO 51 Anti Angiogenesis 51 Exhibitor Profiles 51 Am J Epidemiol 51 targeting CD# 51 pertuzumab 51 Tanespimycin 51 EMBO J. 51 Annual BioPartnering Europe 51 Carfilzomib 51 Clinical Efficacy 51 Cardiology ACC 51 FOOD EXPO 51 PSN# [002] 51 Respiratory Viral Infections 51 dose escalation clinical 51 Traficet EN 51 Anti Tumor 51 HCV SPRINT 51 By Larry Kratka 51 FDA Oncologic Drugs 51 KRN# 51 Free Full Text 51 oral prodrug 51 Neuropsychopharmacology 51 ganetespib 50 BIO VentureForum East 50 Medical Research Katholic 50 InterSolar 50 entinostat 50 Gastroenterology ACG 50 Pirfenidone 50 Fondaparinux 50 Interventional Therapies 50 Biotech Showcase 50 liposome injection 50 Ophthalmology AAO 50 Diabetic Foot 50 Lung Cancer WCLC 50 Optical Communication ECOC 50 FIP Pharmaceutical 50 Recombinant Human 50 Randomized Double blind 50 Inflammatory Bowel Diseases 50 Cell Transplant 50 Edge STudy 50 BioContact Quebec 50 Physical Therapy PTJ 50 Optical Fiber Communications 50 BIO# 50 Communications ECOC 50 Abstract # 50 Acute Myocardial Infarction 50 Inhalation Solution 50 By NATHAN BAIRD 50 ERA D2C Convention 50 Photocure ASA 50 undergoing elective percutaneous 50 LymphoStat B 50 Annual Canaccord Adams 50 Targeted Therapies 50 Protein Therapeutics 50 Phase 2a Clinical Trial 50 CTI Nasdaq 50 WHO TOOK 50 CCX# 50 HCV Protease Inhibitor 50 worsening thrombocytopenia 50 BioPartnering Europe 50 DEERFIELD Ill. Business Wire 50 AA Amyloidosis 50 Nasdaq TARG 50 AIR2 Trial 50 #:#-# [007] 50 ASCO Gastrointestinal Cancers Symposium 50 HIMSS Annual 50 PRNewswire FirstCall Bionovo 50 BiOS 50 Oral Presentations 50 Gastroenterology Week UEGW 50 DDW 50 Obes Res 50 xanthine oxidase inhibitor 50 verteporfin 50 Cellular Therapy ISCT 50 C# BioVentures 50 PRNewswire FirstCall Amylin Pharmaceuticals 50 Glufosfamide 50 Physiology Regulatory Integrative 50 Chest Physicians CHEST 50 Ophthalmology ARVO 50 Patient Adherence 50 Viral Hepatitis 50 Nasdaq ENZN 50 Medicine NEJM 50 Romiplostim 50 Paediatric Oncology SIOP 50 Thermo Scientific booth 50 Novalis Circle 50 Chronic Lymphocytic Leukemia 50 Ann Intern Med 50 IL# PE#QQR 50 Endourology 50 stent DES 50 Crit Rev 50 Prolongs Survival 50 Preclinical Efficacy 50 Needham Biotechnology 50 Prof. Gozes 50 antibody MT# 50 Minimally Invasive Spine Surgery 50 Ambrisentan 50 Hematology Molecular Pathology 50 Medicine ISMRM 50 Anti Infective Drugs 50 Experimental Hematology 50 Cancer EORTC 50 Arch Neurol 50 International Verapamil SR 50 Preclinical Studies 50 Cardiovascular Renal Physiology 50 Safinamide 50 anti amnesic 50 Usenix Security 50 Ophthalmic Drugs Advisory 50 Kaufman Bros. Investor 50 Castration Resistant Prostate Cancer 50 'S ® DOLMIO 50 Nordic ACTI 50 abstracts summarizing 50 Fall VON 50 Endovascular Valve Edge 50 ENDEAVOR III 50 Natixis Bleichroeder Hidden Gems 50 Heart Failure Patients 50 Liver Disease AASLD 50 JMP Securities Research 50 Sangamo BioSciences Announces 50 AEG# 50 iSBTc 50 CTRC AACR 50 Neurological Surgeons CNS 50 relapsed multiple myeloma 50 Viral Infections 50 Ann Rheum Dis 50 dasatinib Sprycel 50 Ovarian PLCO Cancer 50 & EXPO ITEXPO 50 NASDAQ CXSP announced 50 Daclizumab 50 Cardiovascular Interventions 50 Symposium Seminar 50 HDAC Inhibitors 50 Pyridorin 50 Microplasmin 49 ® EBLY ® MASTERFOODS 49 HIF PH inhibitors 49 COU AA 49 Cardiology ESC 49 Hematological Malignancies 49 Namenda Memantine HCl 49 Nephrol Dial Transplant 49 Anticancer Drugs 49 Canaccord Genuity Healthy Living 49 BioCentury Future Leaders 49 Phase III AFFIRM 49 C# BioVentures Conference 49 Nasdaq REGN 49 ThermoDox ® clinical 49 HDL Mimetic Peptide 49 Molecular Diagnostic 49 Cancer Immunotherapy 49 J.P. Morgan SMid Cap 49 PRNewswire FirstCall Genta Incorporated 49 Immunobiology 49 Protein Expression 49 Aircraft Supplier 49 thetreatment 49 REGiMMUNE 49 HCV RESPOND 2 49 Vaccine Immunology 49 phase IIb clinical 49 Multilateral Initiative 49 CRMD# 49 SuperComputing 49 Healthcare Epidemiology 49 Developmental Therapeutics Immunotherapy 49 Institutional Investor Forum 49 Biomolecular Sciences SBS 49 Environ Health Perspect 49 motexafin gadolinium Injection 49 rALLy clinical trial 49 IMiDs R 49 Center ™ NGDC 49 Ann Oncol 49 Hematologic 49 Temsirolimus 49 Inc. Nasdaq AMLN 49 ADVANCE PD 49 ASN Renal Week 49 BY KIMBER SOLANA 49 R roscovitine 49 Experimental Neurology 49 Immunomedics Announces 49 Glycobiology 49 Retina Specialists ASRS 49 HUPO 49 Phase Ib II 49 Immunogenetics 49 Cloretazine ® 49 Inc. Nasdaq ATHX 49 Growth Institutional Investor 49 Remote Sensing ASPRS 49 GLOBE NEWSWIRE Pressure BioSciences 49 Stifel Nicolaus Cleantech 49 Epileptology 49 Pharmacokinetics 49 NYSE Amex RGN 49 Atherosclerosis 49 coronary stent merged 49 Solorel TM 49 YONDELIS 49 customizable drug eluting 49 antibody blinatumomab MT#/MEDI-# 49 Medicine AAPM 49 Vector Borne 49 Gastrointestinal Oncology 49 ESMO 49 Nasdaq SGMO announced 49 Clin Chem 49 Chronic Lymphocytic Leukemia CLL 49 cardiovascular morbidity 49 Gemzar ® 49 Grid Interop 49 Neurodegenerative Disease 49 Microbial Pathogenesis Seminar 49 J Clin Endocrinol Metab 49 JAK1 49 compound AEZS 49 Hyatt Regency Embarcadero 49 Antisense 49 Gastrointestinal Endoscopy ASGE 49 ISSWSH 49 Breast Surgeons ASBS 49 Electrochemical Society 49 Podium Presentation 49 PRNewswire FirstCall Poniard Pharmaceuticals 49 First Patient Enrolled 49 Islet Transplant 49 Cardiol 49 Clinical Oncology 49 Nasdaq IDRA today 49 Cloretazine R 49 teriflunomide 49 IEEE CPMT 49 NASDAQ LIPD 49 Urologic Oncology SUO 49 Exposition OFC 49 GITA Annual 49 Diabetologia 49 Respiratory Disorders 49 Biomolecular Sciences 49 EASD 49 Diabetic Macular Edema 49 EVEREST II 49 RECORD1 49 EGS# 49 Inc. Nasdaq BIOD 49 HCV protease 49 HQK 49 Br J Cancer 49 Fluid Dynamics DFD 49 Thoracic Oncology 49 Platelet Inhibition 49 antitumoral 49 elotuzumab 49 rd Annual 49 Lenocta 49 Refractory Angina 49 EACTS 49 Maven Semantic 49 GW# [003] 49 LIGHTFAIR International 49 Breaking Clinical Trials 49 Androgen Receptor 49 Immunotherapeutics 49 Hand ASSH 49 Solid Tumors 49 PRNewswire FirstCall Genaera 49 Genital Infection 49 Endovascular Therapy 49 Inc. Nasdaq VRUS 49 Oral Microbiology 49 Antiviral 49 oral FTY# 49 QLT# 49 OneMedForum 49 xenograft models 49 cyclophilin inhibitors 49 Oligonucleotides 49 Semafore Pharmaceuticals 49 GRNCM1 49 randomized discontinuation trial 49 SWX BSLN 49 Anesthesiologists ASA 49 Comparative Physiology 49 viral kinetic 49 perifosine KRX 48 Medicinal Chemistry Letters 48 Xcytrin R 48 bazedoxifene conjugated estrogens 48 HDAC Inhibitor 48 European CanCer Organisation 48 International AJAXWorld RIA 48 ARVO Annual Meeting 48 Optical Fiber Communication 48 Ampligen ® 48 Cardiology Scientific Sessions 48 Neurotology 48 DOMAINfest Global 48 #:#-# [033] 48 CBLC# 48 Inc. Nasdaq OPTR 48 Vulnerable Plaque 48 IEEE Symposium 48 IFT Annual Meeting 48 tolvaptan 48 epigenetic therapies 48 Arch Surg 48 International OARSI 48 OMP #M# 48 Interactive Techniques 48 Perinatal Epidemiology 48 Pivotal Clinical Trial 48 Kidney Int 48 Frankfurt XMP 48 Tolvaptan 48 NASDAQ IDRA 48 Science Translational Medicine 48 Nephrology ASN 48 Developmental Therapeutics 48 J Clin Invest 48 PRNewswire FirstCall Nektar Therapeutics 48 Headache Society 48 Nasdaq IMGN 48 metaglidasen 48 #King Bong Paul 48 psoriatic arthritis PsA 48 Thrombosis 48 Nasdaq DNDN 48 Biopharmaceutical Manufacturing 48 Parties CoP 48 American Physiological Society 48 TG MV 48 Luxe Sunset Boulevard 48 Whistler Institutional Investor 48 TMC INTERNET TELEPHONY 48 Stent Thrombosis 48 recurrent glioblastoma multiforme 48 J Natl Cancer Inst 48 www.labopharm.com 48 Gynecol Oncol 48 MEETING AND EXPLANATORY 48 Windhover Information 48 vidofludimus 48 Tesetaxel 48 Nasdaq INCY announced 48 Lisofylline 48 COPIC Energy 48 Therapeutic Advances 48 AMEX CTE 48 Vascular Targeting Agents 48 Photo Optical Instrumentation 48 Cellular Therapy 48 preclinical efficacy 48 MEND CABG 48 taxane resistant 48 Initiated Phase 48 resistant hormone refractory 48 Photovoltaics Summit 48 Ocular Inflammation 48 Investment Symposium OGIS 48 TACI Ig 48 Randomized Phase III 48 Xelox 48 Kyoto Laureate 48 Aggressive Reduction 48 Through Glycoscience R 48 Inc. NASDAQ NBIX 48 CRLX# 48 trial evaluating PRX# 48 Phacilitate Vaccine Forum 48 Pulmonary Hypertension 48 Reliability Physics 48 PRNewswire FirstCall Ardea Biosciences 48 Two Investor Conferences 48 JMP Securities Healthcare 48 Pemetrexed 48 EGFR HER2 48 Cardiovascular Horizons 48 HIMSS# Annual 48 Randomized Phase II 48 Breast Surgeons 48 Well Tolerated 48 AACP Annual Meeting 48 rosuvastatin Crestor 48 DASISION 48 Aplidin R 48 Outpatient Setting 48 Intensive Care Medicine 48 Nexavar sorafenib 48 Dermatology AAD 48 SCCHN 48 ZD# [001] 48 CONNECTIONS TM 48 ATVB 48 Westin Waltham 48 oncolytic virus therapies 48 ECNP 48 midstage clinical 48 Neurochemistry 48 Drug Discovery 48 Intervention Effectiveness 48 Oppenheimer Industrials 48 RNAi Therapeutics 48 comparing alemtuzumab 48 refractory chronic myeloid 48 #:#-#,# [003] 48 NASDAQ INHX 48 AACC Annual Meeting 48 PITTCON 48 Small Molecule 48 michael.amon @ newsday.com 48 HORIZONS AMI 48 Inc. NASDAQ AXYX 48 Surgery ASLMS 48 Perifosine 48 Acute Heart Failure 48 poly ADP ribose polymerase 48 CALGB 48 Tumor Biology 48 Rheumatology ACR 48 Novel Inhibitor 48 Tarvacin TM 48 Marrow Transplantation 48 Tom Burghardt 48 Luxe Sunset Bel Air 48 AAEP Convention 48 TÎ ² 4 48 LD MICRO Conference 48 Neulasta ® 48 Integrative Oncology 48 Arthritis Rheum 48 Imprime PGG ® 48 Ceflatonin R 48 Suppl. 48 TLR antagonists 48 Tumor Microenvironment 48 Liver Disease 48 Archexin 48 Boston Marriott Copley 48 EMBLEM TM 48 #:#-# [031] 48 Central Retinal Vein 48 Inc. Nasdaq BNVI 48 NIH Consensus 48 Inc. Nasdaq CRTX 48 CEQ# 48 Systemic Delivery 48 AIDS Vaccine 48 Inc. Nasdaq DCTH 48 Inc. Nasdaq INFI 48 Frontenac Institutional Investor 48 relapsing remitting MS RRMS 48 galiximab 48 Nasdaq CBST 48 Reports Preclinical Data 48 Interventional Oncology 48 catheter occlusion 48 #:#-# [023]